1. Home
  2. KYMR vs EBC Comparison

KYMR vs EBC Comparison

Compare KYMR & EBC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KYMR
  • EBC
  • Stock Information
  • Founded
  • KYMR 2015
  • EBC 1818
  • Country
  • KYMR United States
  • EBC United States
  • Employees
  • KYMR N/A
  • EBC N/A
  • Industry
  • KYMR Medicinal Chemicals and Botanical Products
  • EBC Accident &Health Insurance
  • Sector
  • KYMR Health Care
  • EBC Finance
  • Exchange
  • KYMR Nasdaq
  • EBC Nasdaq
  • Market Cap
  • KYMR 3.1B
  • EBC 3.4B
  • IPO Year
  • KYMR 2020
  • EBC 2020
  • Fundamental
  • Price
  • KYMR $47.28
  • EBC $17.32
  • Analyst Decision
  • KYMR Strong Buy
  • EBC Buy
  • Analyst Count
  • KYMR 15
  • EBC 1
  • Target Price
  • KYMR $58.53
  • EBC $20.00
  • AVG Volume (30 Days)
  • KYMR 599.5K
  • EBC 1.3M
  • Earning Date
  • KYMR 10-30-2025
  • EBC 10-23-2025
  • Dividend Yield
  • KYMR N/A
  • EBC 3.00%
  • EPS Growth
  • KYMR N/A
  • EBC N/A
  • EPS
  • KYMR N/A
  • EBC N/A
  • Revenue
  • KYMR $44,711,000.00
  • EBC $549,584,000.00
  • Revenue This Year
  • KYMR $58.45
  • EBC $25.13
  • Revenue Next Year
  • KYMR N/A
  • EBC $28.88
  • P/E Ratio
  • KYMR N/A
  • EBC N/A
  • Revenue Growth
  • KYMR N/A
  • EBC N/A
  • 52 Week Low
  • KYMR $19.45
  • EBC $13.51
  • 52 Week High
  • KYMR $53.27
  • EBC $19.40
  • Technical
  • Relative Strength Index (RSI)
  • KYMR 64.57
  • EBC 61.97
  • Support Level
  • KYMR $42.71
  • EBC $16.77
  • Resistance Level
  • KYMR $44.43
  • EBC $17.48
  • Average True Range (ATR)
  • KYMR 1.98
  • EBC 0.37
  • MACD
  • KYMR 0.60
  • EBC 0.00
  • Stochastic Oscillator
  • KYMR 91.51
  • EBC 73.54

About KYMR Kymera Therapeutics Inc.

Kymera Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to reinventing the treatment of human disease through the development of, differentiated medicines that address health problems and that meaningfully improve patients' lives. It is committed to novel technologies to address targets that have known disease-causing biology, but which have not been drugged, or have been inadequately drugged, often based on limitations of existing technologies. Its approach is intended to discover and develop a new generation of medicines in a disease-agnostic manner. Its product pipelines are STAT6, TYK2, and IRAK4.

About EBC Eastern Bankshares Inc.

Eastern Bankshares Inc is a commercial bank that caters its products and services to retail, commercial, and small business customers. Its diversified products and services include lending, deposit, wealth management, and insurance products. The company has one operating segment; Banking business which offers a range of banking lending, savings, and small business offerings, and its wealth management and trust operations.

Share on Social Networks: